Diagnosis and Treatment of Neonatal Diabetes Caused by ATP-Channel Mutations: Genetic Insights, Sulfonylurea Therapy, and Future Directions
Background: Neonatal diabetes (NDM) is a rare genetic disorder diagnosed in infants under six months of age, characterized by persistent hyperglycemia resulting from insufficient or absent insulin production. Unlike the more common forms of diabetes, such as type 1 diabetes (T1D) and type 2 diabetes...
Saved in:
| Main Authors: | Michela Trada, Chiara Novara, Martina Moretto, Edoardo Burzi, Davide Tinti, Luisa De Sanctis |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-02-01
|
| Series: | Children |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2227-9067/12/2/219 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Feasibility of efficacious therapy of diabetes mellitus by sulfonylurea agents in neonates with KCNJII gene mutation: originalobservation
by: Andrey Olegovich Emel'yanov, et al.
Published: (2009-09-01) -
Relationship between the efficacy of sulfonylurea therapy and structural variants of the ABCC8 (rs757110) and KCNJ11 (rs5219) genes in patients with type 2 diabetes mellitus with different phenotypes
by: I. А. Bondar’, et al.
Published: (2024-04-01) -
Neonatal diabetes mellitus due to a new KCNJ11 mutation - 10 years of the patient`s follow-up
by: Maja D Ješić, et al.
Published: (2021-06-01) -
Lack of association between KCNJ11 (rs5219) and ABCC8 (rs757110) polymorphisms and sulphonylurea treatment response in type 2 diabetes patients in Novosibirsk region
by: Irina Arkad'evna Bondar, et al.
Published: (2015-03-01) -
Case Report: Challenges of insulin and sulfonylurea dosing in an extremely premature infant for the management of KCNJ11-associated neonatal diabetes mellitus
by: Ishan Perera, et al.
Published: (2025-04-01)